Preventing Crosscontamination In Pharmaceutical Production Essay

1951 words - 8 pages

Introduction
This assignment will be exploring the areas in production how it is regulated and controlled. It is exploring the rules governing the pharmaceutical production. It gives the guidelines for example to how monitor, prevent and control cross contamination within the pharmaceutical plants. Production operation, validation, starting material from the purchasing stage till manufacturing, packaging materials and operation. Also the quality of the finishing product, rejecting of raw material or end product and returned materials. Due to the word limitation of this assignment exploring each are of the above will be brief.
Discussion
1-Prevention of cross contamination
Cross contamination in pharmaceutical production should be prevented at all the stages of production. It is defined as:
“The process by which foreign chemical, microbial, or physical
substances are unintentionally transferred from one
substance or object to medicines with harmful effects that
might affect the purity and quality of the pharmaceutical
products.”[1]
Cross contamination can occur either by introduction of micro-organisms to the product or by other pharmaceutical products in the mixed plant manufacturing.
Studies showed that main contamination within pharmaceutical production occurs by people, air, equipment, water and or raw materials. [1]
Severity of the cross contamination of medicinal products depends on the route of its administration. Contamination of parenteral products carries more risk to the patient can lead to severe implications varies between severe illness or even death. [2]
Cross contamination should be avoided by strict measures and guidelines summarised as follows:
• According to the Good manufacturing practice guidelines (GMP).
Personnel working in the production area should be wearing protective clothing, regular alcohol hand washing, regular swabbing and adequate training. They have to follow the standard operating procedures (SOP) before entering the production area. [3]
• Examining of the raw material for any signs of contamination and good Laboratory practice (GLP) should be followed for testing the materials.
• Equipment cleaning procedures and cleaning validation should be followed, continuous and regular testing of the equipment for any potential contamination.[4]
• If two types of the products are produced current GMP suggested that there should be separation of time followed by appropriate cleaning.[1]
Detailed cleaning procedure should be available detailing methods of cleaning, type of cleaning products, sampling and testing plan .Residual cleaning limits should be practical achievable and verifiable. [5]
• Air in the production area should be filtered to prevent contamination. Type of filter, replacing filter and validation of air filtering system should be in the SOP. Regular sampling and testing of air should also be maintained.
• Water used widely in the manufacturing processing and in cleaning. Regular...

Find Another Essay On Preventing Crosscontamination in Pharmaceutical Production

Company Ethics and Moral Essay

1398 words - 6 pages need in developing countries and to victims of natural disasters and civil unrest throughout the world. Not only do these pharmaceutical companies give back to society through charitable organizations, they also create jobs for many Canadians. “The generic pharmaceutical industry provides direct employment to 11,000 workers in Ontario and Quebec, offering well-paid, highly skilled jobs in research and development, production and operations. This

Medicine and Drugs - Direct to Consumer Pharmaceutical Marketing

1634 words - 7 pages academic investigators. Since public money lays the groundwork for pharmaceutical production, drug companies have a responsibility to the taxpayers not to engage in practices that will result in a reduction in the quality of healthcare. The major problems underlying this situation is that, under our current insurance structure, the costs of increasing drug prices do not accrue to the consumer and thus do not decrease demand as they should in a free

Future of "Big Pharma"

2421 words - 10 pages medicines over the next decade .Alternatives: Line extension2. Evergreening3. New and Improved4. More haste5. Two is better than one6. Old drug, new use7. Targeting the consumerFacts Considered: The United States, Western Europe and Japan consumed 84% of the world's total production of pharmaceuticals.2. Many LDCs experiencing income growth, and expected to purchase larger quantities as time passes.3. In many countries population was aging, causing

“The competitive position of a company is determined by the industry structure in which it competes.” Critically evaluate this statement.

4509 words - 18 pages and laws as well as changes in the environment hinder sometimes the production of drugs as well as the sales (Lin & Darling, 1999).Furthermore, the pharmaceutical industry in Greece experiences great dispute, as the state focuses on issues of pricing instead of trying to balance expenditures. This phenomenon results to an increase in the fees of customers' insurance, which also leads to social protest and industry disapproval (Contiades, et al

Intellectual Property

1129 words - 5 pages 355 of the Federal Food, Drug, and Cosmetic Act of 1997 it is stated that, it is not necessary to submit a registration for a generic drug if that drug is demonstrated to be similar to a medical product. Exclusivity in the pharmaceutical world is told to be used because it helps the developer come up with the costs of production and research as mentioned earlier. The initial registrant, who is the person that submitted the request to produce the

Supply and Demand: Pharmaceuticals

860 words - 3 pages pharmaceutical companies to build expensive plants to supply the one or two doses needed for most vaccines when companies can make more money manufacturing a drug that people will take daily for chronic conditions. Along with the decrease in the production of vaccinations by pharmaceutical companies, another major concern that is adding to the problem is lawsuits. "The vaccine industry today is worth $6.7 billion, approximately, and lawsuits out

A Case Study of Operational Strategies Adopted By Jyoti Remedies

2730 words - 11 pages destination followed by Russia, Germany and Austria. Low cost of production and research and development (R&D) boosts efficiency of pharma companies in India. The cost of production in the country is approximately 60 per cent lower than that of the US and almost half of that of Europe. (INDIAN PHARMACEUTICAL SECTOR, 2013) India exports all forms of pharmaceuticals from Active Pharmaceutical Ingredients to formulations, both in modern medicine and

The Global Pharmaceutical Market Forecast

2415 words - 10 pages MARKET OVERVIEW The global pharmaceutical market is a multibillion-dollar industry. The 10 largest drug companies control over one-third of the market, several with sales of more than $10B a year and profit margins of 30%. Six of these companies are based in the U.S. and four are in Europe. It is predicted that North and South America, Europe, and Japan will continue to dominate by accounting for 85% of the world’s pharmaceutical market

GlaxoSmithKline's Corporate Social Responsibility Practices.

4251 words - 17 pages Table of contents:1) Introduction.2) Pharmaceutical sector in general, main arguments put forward by the companies and counter-arguments.3) GlaxoSmithKlein's CSR claims and counter-evidence:i) Medicines for the developing world.ii) Business ethics and integrity.iii) Environment, health and safety.iv) Research and development.4) Concluding remarks.5) References.6) Appendices.1. Introduction.The global pharmaceutical industry has long been

Geophagia

793 words - 4 pages . Negatively charged clay molecules easily bond to positively charged toxins in the stomach and gut—for that reason preventing toxins from entering into the bloodstream by transmitting them through the intestines and out of the body in the form of feces. To start off, geophagia is most commonly associated with pregnancy. Not only do pregnant women ingest dirt for the reason that they require extra calcium as the fetal skeleton develops, but also for

The pharaceutical industry

851 words - 3 pages An important and sometimes overlooked factor that distinguishes one company from another in the pharmaceutical industry is strategic planning.Porter's model looks at the competitive arena in which businesses operate and describes five basic competitive forces that directly impact on how successfully a business unit operates. By understanding and knowing what these competitive forces are and how they impact on the business, managers are better

Similar Essays

Role Of Social Media In Pharmaceutical Marketing

1514 words - 6 pages in internet marketing could lead to a huge impact in pharmaceutical industry. How pharmaceutical firms can better implement the social technology? It can enhance the role of social technology in accordance with FDA regulation and emphasizing on pharmacovigilance. Pharmacovigilance is the term used for assessing, monitoring, detecting and preventing adverse effects of drugs. Pharmaceutical firms should monitor adverse drug reaction cause to

An Analysis Of The Pharmaceutical Industry Using Porter's Five Force Model, Pest, Bcg Matrix And Predicting Future Prospects.

3089 words - 12 pages £ millionPharma R&D as a % of output1197242719855461419901,1401719911,2391719921,4201719931,7072119941,9182019951,9031919962,0782019972,2512119982,3762319992,7852320002,8462520013,040242002e3,172naSourceResearch and Development in UK Business (ONS)UK Pharmaceutical R&D Expenditure, CMR InternationalAnnual Census of Production (ONS)Generic drug manufactures are usually first developed by the patented prescription drug makers (or they

Kv Pharmaceuticals Case Study

4368 words - 17 pages manufacturing and distributing drugs until the company acquires FDA approval to continue with production. This will continue until KV Pharmaceutical maintains a five-year consecutive compliance with the Good Manufacturing Practices regulations, and also with the new drug approval requirements. KV Pharmaceuticals and its officers are also prevented from manufacturing and distributing any drugs from the production plants until they are in compliance with

Pharmaceutical Companies Stand In The Way Of Treatment

3821 words - 15 pages Pharmaceutical Companies Stand in the Way of Treatment Abstract This casebook concentrates on the negative effects that the pharmaceutical industry’s trade and production policies have on third world nations suffering from disease epidemics. My position is that pharmaceutical companies are not concerned with the health benefits of their drugs, but rather with the market that their drugs generate. I illustrate this notion by describing the